CEO Peter Beck Sells $286 Million in Pre-Planned Stock Sale
RKLB has more than doubled off its 52-week low of $37.57.
Summary
Rocket Lab CEO Peter Beck sold 3.28 million shares worth $286.4 million through a pre-planned 10b5-1 trading plan.
Key Events · Ownership and Investor Activity · RKLB
-
CEO Sells Significant Stake
CEO Peter Beck disposed of 3,275,779 shares of common stock.
-
Substantial Transaction Value
The total value of the shares sold amounted to approximately $286.4 million.
-
Pre-Planned Sale
The sales were executed automatically between July 6-8, 2026, pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2026.
-
Post-Transaction Holdings
Following these transactions, Peter Beck's indirect holdings via trust are 4,786,894 shares.
Analysis · RKLB · Manufacturing
Rocket Lab CEO Peter Beck executed a substantial pre-planned sale of company stock totaling over $286 million. While these transactions were conducted under a Rule 10b5-1 trading plan adopted in March 2026, indicating they were not based on new, non-public information, the sheer magnitude of the sale by a key executive is notable. This comes amidst a period of significant positive news for Rocket Lab, including record Q1 results, Nasdaq-100 inclusion, and a major acquisition of Iridium Communications. Investors may view such a large divestment by the CEO as a move to diversify personal holdings, but it still represents a significant reduction in direct insider exposure.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 29.8% of the 1984 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.03%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RKLB was trading at $84.67 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $49.9B. The 52-week trading range was $37.57 to $151.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.